GlycoMimetics
Acquired
- Employees
- 11–50
- Business Model
- B2B
- Website
- glycomimetics.com
- Total Funding
- $38.0M
- Last Round
- $38.0M Venture Round
About
GlycoMimetics was a Rockville, Maryland-based clinical-stage biotechnology company that discovered and developed glycobiology-based therapies targeting cancers and inflammatory diseases. Its leading program uproleselan targeted E-selectin in acute myeloid leukemia. In June 2025, GlycoMimetics merged with Crescent Biopharma.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account